By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: If It’s Unnecessary, Who Cares Which Stent Is Better?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Specialties > Cardiology > If It’s Unnecessary, Who Cares Which Stent Is Better?
CardiologyMedical DevicesNews

If It’s Unnecessary, Who Cares Which Stent Is Better?

gooznews
gooznews
Share
5 Min Read
SHARE

The Lancet in its latest edition has another “paradigm-shifting” study (its words) on whether invasive cardiologists should use bare metal or drug-eluting stents in people with coronary blockages. For those not following this issue, the medical literature has been bouncing like a yo-yo on the question of which stents — drug-eluting or bare-metal — are better at preventing thrombosis or blood clots that can form around the stents, which sometimes lead to heart attacks and require repeat operations.

The Lancet in its latest edition has another “paradigm-shifting” study (its words) on whether invasive cardiologists should use bare metal or drug-eluting stents in people with coronary blockages. For those not following this issue, the medical literature has been bouncing like a yo-yo on the question of which stents — drug-eluting or bare-metal — are better at preventing thrombosis or blood clots that can form around the stents, which sometimes lead to heart attacks and require repeat operations.

The researchers, mostly European but led by Gregg Stone of the Cardiovascular Research Foundation at Columbia University, looked at the results of 49 trials in over 50,000 patients who were given four different types of drug-eluting or bare-metal stents. One particular brand of drug-eluting stent — the cobalt-chromium everolimus eluting stents produced by Abbott Labs — reduced stent thrombosis within 30 days after the operation by anywhere from 14 to 41 percent compared to the other options. “If confirmed in future randomized trials, (the findings) represents a paradigm shift,” Stone, a consultant to Abbott and other stent manufacturers, and the other authors noted in their conclusion.

Sound pretty impressive, right? But how often does this problem happen to people with heart disease who get stents? According to a 2005 study that looked at drug-eluting and bare-metal stents, the incidence of thrombosis in either group was somewhere between 1.3 and 1.7 percent. Or, to put it another way, it affects between 13 and 17 in every 1,000 patients. So a reduction of 14 to 41 percent — the game-changing stats for choosing one brand of stent over another — would be a reduction in thrombosis of 2 to 7 in 1,000 patients.

More Read

Nutritionist
How To Know If Your Nutritionist Is Legit
Mobilizing Stakeholders For Better Health, Better Care And Lower Costs
The High Strength Surgical Adhesive Market
See you at the BBJ Future of Healthcare ‘Power Breakfast’
Total Artificial Heart Patient Bridged To Transplant

Compare those benefits to the waste in the entire intervention cardiology system. A study reported last summer in the Journal of the American Medical Association found that an estimated 15 percent of the 600,000 angioplasties done every year, which often result in the insertion of stents, are either inappropriate or their necessity is uncertain. Add on top of that the fact that the COURAGE trial results released in 2007 showed that drug intervention (primarily statins) worked just as well or better than angioplasty in patients with stable coronary artery disease (cost: $1,000 a year or less if generics are used compared to $20,000 for the operation that can lead to stents).

Sadly, a subsequent study showed there had been no change in cardiology practice in the wake of the COURAGE trial. Clearly, the word isn’t getting out that these stents may be unnecessary. A real paradigm shift would be when medical journals like the Lancet stop publishing thinly-disguised marketing studies touting the benefits of one over the other without any perspective on the issue as a whole.

So I don’t end on a downer note, here’s some good news on this subject. The legislature in my home state of Maryland last week passed a bill that will allow for external peer review process to ensure medical necessity for stent placements at local hospitals. The law comes in the wake of a high-profile case of overstenting involving Mark Midei, MD, who was once feted with a pig roast for inserting 30 stents in a day at St. Joseph Medical Center in Towson, Md. Many of them were later found to be unnecessary. The bill, which now goes Gov. Martin O’Malley for signing, also mandates a certificate of need for new facilities that can perform invasive cardiology procedures.

TAGGED:cardiac stents
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

patient communities
BusinessDiagnosticseHealthHealth ReformHome HealthHospital AdministrationMedical DevicesMedical EducationMedical InnovationsMedical RecordsMobile HealthNewsPolicy & LawPublic HealthSocial MediaTechnologyWellness

Top Digital Health Innovations That Will Transform Healthcare

September 24, 2013
free speech
NewsPolicy & LawPublic Health

Physicians Lose Right of Free Speech

August 20, 2014
Medical DevicesMedical InnovationsTechnology

Are Wearables the Future of Clinical Trials?

July 8, 2016
Medical Devices

The Keys To Maintaining Safety With Medical Equipment

February 11, 2020
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?